US › Healthcare

Curanex Pharmaceuticals Inc Common Stock (CURX)

US · Healthcare · Biotechnology

$4.60+9.79%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.3M

EPS

$-0.03

Key statistics

Market cap

$7.1M

Forward P/E

0.0

P/B

1.49

Book value

$3.38

EPS (TTM)

$-7.38

52-week high

$183.59

52-week low

$3.58

50-day MA

$4.35

200-day MA

$6.76

Shareholding

Insiders

61.35%

Institutions

1.06%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.35%
Citadel Advisors Llc	0.30%
TWO SIGMA SECURITIES, LLC	0.18%
XTX Topco Ltd	0.16%
Two Sigma Investments LLC	0.09%
Citigroup Inc	0.06%
Ground Swell Capital, LLC	0.04%
Jump Financial LLC	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Curanex Pharmaceuticals Inc Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.